LGVAX | VIVAX | LGVAX / VIVAX | |
Total Expense Ratio | 1.01 | 0.17 | 594% |
Annual Report Gross Expense Ratio | 1.04 | 0.17 | 612% |
Fund Existence | 16 years | 33 years | - |
Gain YTD | 4.629 | 6.724 | 69% |
Front Load | 6% | N/A | - |
Min. Initial Investment | 1000 | 3000 | 33% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 3.88B | 195B | 2% |
Annual Yield % from dividends | 0.77 | 2.06 | 37% |
Returns for 1 year | 0.87 | 9.76 | 9% |
Returns for 3 years | 17.77 | 34.31 | 52% |
Returns for 5 years | 33.42 | 74.87 | 45% |
Returns for 10 years | 55.35 | 116.32 | 48% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
CRRYX | 14.49 | 0.11 | +0.76% |
Columbia Small Cap Value II Inst3 | |||
DBOYX | 25.34 | 0.10 | +0.40% |
BNY Mellon Balanced Opportunity Y | |||
GFVIX | 16.06 | 0.06 | +0.37% |
Goldman Sachs Focused Value Inv | |||
HFYCX | 12.54 | -0.02 | -0.16% |
Hartford Schroders Intl Multi-Cp Val C | |||
RRIGX | 21.75 | -0.04 | -0.18% |
T. Rowe Price International Value Eq R |